FDA Drug recall D-0232-2022
Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Phar…
- FDA Drug
- Class II
- terminated
- Published 2021-11-24
On 2021-11-24 the FDA classified a Class II recall of Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Phar… by Teva Pharmaceuticals Usa, citing labelling: Incorrect Exp. Date.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0232-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-10-27 |
| Published | 2021-11-24 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Teva Pharmaceuticals Usa |
| Distribution | US |
Product
Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054; (b) Manufactured By: Actavis Laboratories FL. Inc, Fort Lauderdale FL. 33314 USA, Distributed by Avista Pharma Inc. Parsippany, NJ 07054 USA. NDC 62037-597-90
Reason
Labelling: Incorrect Exp. Date
Identifiers
| ndc | 62037-597-90 |
|---|---|
| ndc | 62037-597-05 |
| ndc | 62037-598-90 |
| ndc | 62037-598-05 |
| ndc | 62037-599-90 |
| ndc | 62037-599-05 |
| ndc | 62037-600-90 |
| ndc | 62037-600-05 |
| code_info | Lot # 100023805, Exp. Date 05/2023 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0232-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.